The clinical manifestations of disease are now days comprehend by the crucial aspect i.e. Genetics. In the last decade, a lot of work has been done to understand the underlying molecular mechanisms of different cardiac diseases. These developments changed the scenario from a clinical basis to the genetic basis and provided new therapeutic approaches for the prevention of diseases. Through genetic basis, it has been tried to understand the molecular mechanisms, although restrictive cardiomyopathy (RCM) is far more behind in terms of genetics than other cardiomyopathies such as dilated cardiomyopathy (DCM), and hypertrophic cardiomyopathy (HCM).
